2026-10-19T01:07:01Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/request

oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/134712026-10-18T21:13:27Zopenairedrivercom_ebyu_10000col_ebyu_10001

Impact of coronaphobia on treatment and follow-up compliance of cancer patientsAkagunduz, BaranOzer, MuhammetKaracin, CengizAtcl, Muhammed MustafaYlldlrlm, Hasan CagrlUnver, EdhemcancercoronaphobiaCOVID-19follow-up compliancepandemicphobiatreatmentAdultAgedAged, 80 and overFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedNeoplasmsPatient CompliancePhobic DisordersPsychometricsSARS-CoV-2Young Adultanxiety assessmentArticlecancer patientchildcolorectal cancercontrolled studycoronavirus disease 2019COVID 19 Phobia Scaledisease associationThe aim of this study was to assess the impact of coronaphobia on treatment and follow-up compliance in cancer patients. The records of 230 cancer patients were reviewed. Coronaphobia was assessed via the validated COVID-19 Phobia Scale (C19P-S). A total of 64% of the patients had a high coronaphobia score. Among them, 59% were noncompliant. In multivariate logistic regression analysis, low educational status, treatment type, following COVID-19 news, having knowledge about COVID-19 transmission and higher C19P-S score were associated with noncompliance (p = 0.006, p < 0.001, p = 0.002, p = 0.002 and p = 0.001, respectively). Multivariate analysis revealed that having knowledge about COVID-19 transmission was related to a higher C19P-S score (p = 0.001). The cancer patients studied had significant coronaphobia. Moreover, greater coronaphobia was significantly associated with noncompliance with follow-up and treatment. © 2021 Future Medicine Ltd.. All rights reserved.Future Medicine Ltd.2021Articlehttps://rdlopen.rawdatalibrary.net/r/ebyu/13471https://doi.org/10.2217/fon-2021-00201479-6694enFuture Oncologyinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/13471